Quick-Med Signs License With Medline To Provide Stay-Fresh® Antimicrobial Technology For Traditional Wound Care Products
GAINESVILLE, Fla. — February 28, 2014 — Quick-Med Technologies Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has licensed its Stay Fresh® technology to Medline Industries Inc. for use in traditional wound care products for both retail and institutional sale in the North American Market.
"We are very excited to work together with Medline to commercialize our Stay Fresh technology for the traditional wound care market," said Bernd Liesenfeld, Quick-Med's president. "Our technologies are specifically designed to be effective against resistant organisms like MRSA and to prevent new resistant bacteria from emerging. Medline has an unparalleled distribution network between retail and insitutional sectors. They allow us together to provide the greatest possible population with safe, effective antimicrobial products in support of infection prevention and control programs."
"Stay Fresh antimicrobial activity is based on peroxide, which is the chemical mechanism utilized by the body's own neutrophils to kill invading pathogens, and therefore provides optimum biological safety," notes Professor Gregory Schultz, director, Institute for Wound Research; and professor of Obstetrics and Gynecology, University of Florida. "This is an exciting new technology that is well suited for the traditional wound care field since peroxide is effective against a broad array of microbes, including antibiotic resistant species of public health importance, while also posing little risk of allowing microbes to develop resistance to it."
Posted March 4, 2014
Source: Quick-Med Technologies